Skip to main content
John Reagan, MD, Oncology, Providence, RI, Rhode Island Hospital

JohnLeonardReaganMD

Oncology • Providence, RI

Assistant Professor of Medicine,The Warren Alpert Medical School of Brown University, Division of Hematology/Oncology, Rhode Island Hospital/The Miriam Hospital

Join to view full profile

Dr. Reagan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Reagan's full profile

Already have an account?

Summary

  • I work primarily with benign and malignant hematological disorders. I am also involved in research in which we give patients with resistant leukemia or lymphoma half matched donor cell infusions. The patients reject the donor cells and in the process retrain their own immune system cells to recognize the tumor.

Education & Training

  • Brown University
    Brown UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Brown University
    Brown UniversityChief Residency, Internal Medicine, 2009 - 2010
  • Brown University
    Brown UniversityResidency, Internal Medicine, 2007 - 2009
  • Brown University
    Brown UniversityInternship, Internal Medicine, 2006 - 2007
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 2006

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2006 - 2024
  • MA State Medical License
    MA State Medical License 2011 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Special Fellow in Clinical Research The Leukemia and Lymphoma Society, 2013
  • Arnold P. Gold Humanism Society 2005

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma
    John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
    John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia
    John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Outcomes Associated with Antimicrobial Use during High Dose Cytarabine Consolidation in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Lifespan Cancer Institute Secures Key Approval for Stem-Cell Therapy for Cancer Patients
    Lifespan Cancer Institute Secures Key Approval for Stem-Cell Therapy for Cancer PatientsJune 21st, 2022
  • Lifespan’s Sickle Cell Clinic Considered a One-Stop Shop for Patients
    Lifespan’s Sickle Cell Clinic Considered a One-Stop Shop for PatientsSeptember 23rd, 2021

Professional Memberships

Hospital Affiliations

Dr. John Reagan, Dr. John Reagan, MD, Dr. J Reagan, Dr. John Leonard Reagan